Organization of the interferon-inducible 2′,5′-oligoadenylate- dependent ribonuclease L (RNase L) gene of mouse

Molecular Biology Reports

Volumn 34, Issue 2, 2007, Pages 97-104

  Pandey, Mitali ^a   Rath, Pramod C ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

5 flanking DNA; Antiviral response; Gene structure; Interferon; Murine RNase L

Indexed keywords

DNA; INTERFERON; RIBONUCLEASE L;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; ENZYME DEGRADATION; EXON; GENE MAPPING; GENE STRUCTURE; GENETIC ORGANIZATION; MALE; MOLECULAR PROBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; RAT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTHERN BLOTTING; VIRUS INHIBITION;

5' FLANKING REGION; ANIMALS; ENDORIBONUCLEASES; EXONS; FEMALE; INTERFERONS; MICE; RESTRICTION MAPPING; SIGNAL TRANSDUCTION;

MAMMALIA; MURINAE;

EID: 34247599012     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-006-9020-z     Document Type: Article

References (31)

1. Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD (1998) How cells respond to intererons. Annu Rev Biochem 67:227-264
2. Darnell JE, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins. Science 264:1415-1421
3. Williams BRG (1999) PKR; a sentinel kinase for cellular stress. Oncogene 18:6112-6120
4. Pavlovic J, Staeheli P (1991) The antiviral potentials of Mx proteins. J Interferon Res 11:215-219
5. Silverman RH, Cirino NM (1997) RNA decay by the interferon regulated 2-5A system as a host defence against viruses. In: Morris DR, Harford JB (eds) mRNA metabolism and post-transcriptional gene regulation. John Wiley & Sons, New York, pp 295-309
6. Zhou A, Paranjape JM, Der S, Williams BRG, Silverman RH (1999) Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258:435-440
7. Silverman RH (1997) 2-5A-Dependent RNase L: a regulated endoribonuclease in the interferon system. In: D'alessio G, Riordan JF (eds) Ribonucleases: structures and functions. Academic Press, New York, pp 515-551
8. Rebouillat D, Hovanessian AG (1999) The human 2′5′- oligoadenylate synthetase family: IFN-induced proteins with unique enzymatic properties. J Interferon Cytokine Res 19:295-308
9. Zhou A, Hassel BA, Silverman RH (1993) Expression cloning of the 2-5A-dependent RNase: a uniquely regulated mediator of interferon action. Cell 72:753-765
10. Bork P, Sander C (1993) A hybrid protein kinase-RNase in an interferon-induced pathway? FEBS Letts 334:149-152
11. Dong B, Silverman RH (1995) 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J Biol Chem 270:4133-4137
12. Cole JL, Carroll SS, Kuo LC (1996) Stoichiometry of 2′,5′- oligoadenylate-induced dimerization of ribonuclease L. A sedimentation equilibrium study. J Biol Chem 271:3979-3981
13. Naik S, Paranjape JM, Silverman RH (1998) RNase L dimerization in a mammalian two-hybrid system in response to 2′,5′-oligoadenylates. Nucl Acids Res 26:1522-1527
14. Diaz-Guerra M, Rivas C, Esteban M (1999) Full activation of RNase L in animal cells requires binding of 2-5A within ankyrin repeats 6 to 9 of this interferon-inducible enzyme. J Interferon Cytokine Res 19:113-119
15. Williams BRG, Kerr IM, Gilbert CS, White CN, Ball LA (1978) Synthesis and breakdown of pppA2′p5′A2′p5′A and transient inhibition of protein synthesis in extracts from interferon-treated cells. Eur J Biochem 92:455-562
16. Benoit De Coignac A, Bisbal C, Lebleu B, Salehzada T (1998) cDNA cloning and expression analysis of the murine ribonuclease L inhibitor. Gene 209:149-156
17. Martinand C, Salehzada T, Silhol M, Lebleu B, Bisbal C (1998) The RNase L inhibitor (RLI) is induced by double-stranded RNA. J Interferon Cytokine Res 18:1031-1038
18. Kerr IM, Brown RE (1978) pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci, USA 75:256-260
19. Dong B, Silverman RH (1999) Alternative function of a protein kinase homology domain in 2′,5′-oligoadenylate dependent RNase L. Nucl Acids Res 27:439-445
20. Dong B, Silverman RH (1997) A Bipartite Model of 2-5A-dependent RNase L. J Biol Chem 272: 22236-22242
21. Dong B, Xu L, Zhou A, Hassel BA, Lee X, Torrence PF, Silverman RH (1994) Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase. J Biol Chem 269:14153-14158
22. Castelli JC, Hassel BA, Wood KA, Li XL, Amemiya K, Dalakas MC, Torrence PF, Youle RJ (1997) A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J Exp Med 186:967-972
23. Diaz-Guerra M, Rivas C, Esteban M (1997) Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology 236:354-363
24. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH (1997) Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J 16:6355-6363
25. Hewish DR, Burgoyne LA (1973) Chromatin sub-structure - the digestion of chromatin DNA at regularly spaced sites by a nuclear deoxyribonuclease. Biochem Biophys Res Commun 52:504-510
26. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York
27. Silverman RH (2003) Implications for RNase L in prostate cancer biology. Biochemistry 42:1805-1812
28. Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM (2006) DNA motifs associated with aberrant CpG island methylation. Genomics. 87:572-579
29. Joerger AC, Ang HC, Veprintsev DB, Blair CM, Fersht AR (2005) Structure of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations. J Biol Chem 280:16030-16037
30. Hassel BA, Zhou A, Sotomayor C, Maran A, Silverman RH (1993) A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 12:3297-3304
31. Williams BRG (2000) Principles and practice of the biologic therapy of cancer, 3rd edn. Lippincott Williams and Wilkins, Philadelphia